October 25, 2024

---

Biotalys appoints Kamal El Mernissi as Chief Business Development Officer

October 17, 2024

---

Biotalys announces closing of private placement

Biotalys obtains subscription commitments for EUR 15 million through a private placement of new shares with new and current investors

October 2, 2024

---

Biotalys expands R&D pipeline with new biofungicide program - BioFun-8 will focus on combatting alternaria in fruits, vegetables and potato crops

September 20, 2024

---

Biotalys granted patents for its first biofungicide, Evoca, in both Europe and the United States

September 11, 2024

---

Biotalys receives approval for large-scale demonstration trials of its first biofungicide candidate, Evoca, in the Netherlands

August 27, 2024

---

Biotalys reports half-year 2024 financial results and business highlights

May 3, 2024

---

Biotalys starts field trials for second biofungicide

February 23, 2024

---

Biotalys reports full-year 2023 financial results and business highlights

February 9, 2024

---

Biotalys enters into academic collaborations with key scientific leaders in Europe and the U.S.

December 20, 2023

---

Biotalys announces results of independent field trials in the U.S.

December 6, 2023

---

Biotalys provides company update - Review by new CEO Kevin Helash leads to focus on core capabilities and organizational changes

November 30, 2023

---

Biotalys provides company update

October 6, 2023

---

Kevin Helash commences role as Chief Executive Officer of Biotalys

October 3, 2023

---

Biotalys announces the appointment of Kevin Helash as Chief Executive Officer and Director to lead the company in its next growth phase

August 24, 2023

---

Biotalys reports half-year 2023 financial results and business highlights

June 12, 2023

---

Biotalys announces closing of private placement

June 8, 2023

---

Biotalys strengthens relationship with investors via private placement of new shares for €7 million

May 31, 2023

---

Biotalys continues to demonstrate strength of first biocontrol in latest global field trials

April 24, 2023

---

Syngenta and Biotalys enter into strategic partnership in biologicals innovation to advance solutions for sustainable agriculture 

March 15, 2023

---

Biotalys announces Chief Financial Officer succession plan - Deputy CFO Douglas Minder to become CFO as of July 2023

February 28, 2023

---

Biotalys reports full-year 2022 financial results and business highlights

January 27, 2023

---

Biotalys achieves significant progress in manufacturing capabilities for its first biocontrol product, Evoca

October 24, 2022

---

Biotalys and Novozymes announce successful Evoca feasibility study - Partners identify new ways to scale Biotalys’ first biofungicide more cost-efficiently

August 19, 2022

---

Biotalys reports half-year 2022 financial results and business highlights

June 22, 2022

---

Biotalys and Novozymes enter into partnership to expand opportunities for Evoca biocontrol

May 26, 2022

---

Biotalys’ first biocontrol Evoca wins World BioProtection Award 2022 for Best Biofungicide Product

May 3, 2022

---

Biotalys obtains new fungicide resistance class for its first biofungicide

April 19, 2022

---

Biotalys appoints Michiel van Lookeren Campagne to Board of Directors - Prominent industry leader strengthens company’s leadership in plant science and technology

March 31, 2022

---

Biotalys appoints Carlo Boutton as Chief Scientific Officer - Company expands executive team with respected science leader to drive biocontrol innovation